You are here

Elizabeth Brydon

Elizabeth Brydon

Liz Brydon is an associate research scientist in the Cardiovascular Disease Initiative (CVDi) under Bayer and the Broad Institute of MIT and Harvard. She focuses on discovering pathways involved in cardiomyopathy and elucidating drug targets in an effort to treat or prevent disease progression. Her work primarily involves generating stem cell lines, differentiating stem cells to cardiomyocytes, and performing assays on stem cell derived cardiomyocytes in a high-throughput setting, notably using high-content imaging platforms.

Prior to joining the CVDi group in 2020, Brydon worked in a gene therapy lab at Massachusetts Eye and Ear Infirmary under Eric Pierce, where she developed a successful gene therapy for PRPF31-related retinitis pigmentosa under Pierce’s and Rosario Fernandez-Godino’s guidance. 

Brydon graduated with a B.S. in biochemistry & molecular biology from Rhodes College in 2018 and has plans to attend graduate school in the coming years.

September 2021